Ana Osorio

9PUBLICATIONS
186CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersHaematological tumoursGene mappingFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Daniel R Barnes, Jonathan P Tyrer, Joe Dennis

|Apr 19, 2023
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

Denise G O'Mahony, Susan J Ramus, Melissa C Southey

|Nov 03, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.

Ashley Weir, Eun-Young Kang, Nicola S Meagher

|Nov 02, 2022
Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility.

Carolina Villarroya-Beltri, Ana Osorio, Raúl Torres-Ruiz

|Oct 14, 2022
A Large Case-Control Study Performed in Spanish Population Suggests That <i>RECQL5</i> Is the Only RECQ Helicase Involved in Breast Cancer Susceptibility.

Erik Michel Marchena-Perea, Milton Eduardo Salazar-Hidalgo, Alicia Gómez-Sanz

|Oct 06, 2022
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Christopher Hakkaart, John F Pearson, Louise Marquart

Pageof 2

Frequent Collaborators

5 joint publications

Miguel de la Hoya

4 joint publications

Anna Jakubowska

4 joint publications

Beth Y Karlan

3 joint publications

Inge Sokilde Pedersen